# The Anesthetic and Analgesic Effect of Adjunct Liposomal Bupivacaine in Periodontal Surgical Procedures

> **NCT07725731** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 58 (actual)

## Conditions studied

- Periodontal Surgery

## Interventions

- **DRUG:** 0.5% Bupivacaine HCl
- **DRUG:** Liposomal Bupivacaine (EXPAREL®)/Bupivacaine

## Key facts

- **NCT ID:** NCT07725731
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-02
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-06-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725731, "The Anesthetic and Analgesic Effect of Adjunct Liposomal Bupivacaine in Periodontal Surgical Procedures". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07725731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
